Global Oxaliplatin Market Research Report 2024

Publisher Name :
Date: 08-Jan-2024
No. of pages: 104
Inquire Before Buying

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.

In this report, only The finished drug is covered, exclude API.

The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% during The forecast period 2024-2030.

Europe is The largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

This report aims to provide a comprehensive presentation of The global market for Oxaliplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Oxaliplatin.

Report Scope

The Oxaliplatin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Oxaliplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Oxaliplatin companies, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Sanofi-Aventis

- Yakult honsha

- Dr Reddy's laboratories

- Sun Pharmaceutical

- Teva

- Fresenius Kabi

- Hospira

- Mylan

- Jiangsu Hengrui Medicine

- Nanjing Pharmaceutical Factory

- Jiangsu Aosaikang Pharmaceutical

- Qilu Pharmaceutical

- Hisun Pharmaceutical

- Lunan Pharmaceutical

- Luoxin

- Halfsky Pharmacy

- YRPG

- Hainan Jinrui Pharmaceutical

- Jari Pharmaceutical

- Chiatai Tianqing

Segment by Type

- Mannitol

- Glucose Solution

- Lactose Solution

- Others

Segment by Application

- Colorectal Cancer

- Stomach Cancer

- Ovarian Cancer

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by companies in The industry, and The analysis of relevant policies in The industry.

Chapter 3: Detailed analysis of Oxaliplatin companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa Segment by country. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and capacity of each country in The world.

Chapter 11: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of The report.

Global Oxaliplatin Market Research Report 2024

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2019-2030)
2.2 Oxaliplatin Growth Trends by Region
2.2.1 Global Oxaliplatin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oxaliplatin Historic Market Size by Region (2019-2024)
2.2.3 Oxaliplatin Forecasted Market Size by Region (2025-2030)
2.3 Oxaliplatin Market Dynamics
2.3.1 Oxaliplatin Industry Trends
2.3.2 Oxaliplatin Market Drivers
2.3.3 Oxaliplatin Market Challenges
2.3.4 Oxaliplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxaliplatin Players by Revenue
3.1.1 Global Top Oxaliplatin Players by Revenue (2019-2024)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2019-2024)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2023
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2019-2024)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2025-2030)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2019-2024)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oxaliplatin Market Size (2019-2030)
6.2 North America Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oxaliplatin Market Size by Country (2019-2024)
6.4 North America Oxaliplatin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size (2019-2030)
7.2 Europe Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oxaliplatin Market Size by Country (2019-2024)
7.4 Europe Oxaliplatin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size (2019-2030)
8.2 Asia-Pacific Oxaliplatin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oxaliplatin Market Size by Region (2019-2024)
8.4 Asia-Pacific Oxaliplatin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oxaliplatin Market Size (2019-2030)
9.2 Latin America Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oxaliplatin Market Size by Country (2019-2024)
9.4 Latin America Oxaliplatin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size (2019-2030)
10.2 Middle East & Africa Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oxaliplatin Market Size by Country (2019-2024)
10.4 Middle East & Africa Oxaliplatin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Detail
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis Oxaliplatin Introduction
11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2019-2024)
11.1.5 Sanofi-Aventis Recent Development
11.2 Yakult honsha
11.2.1 Yakult honsha Company Detail
11.2.2 Yakult honsha Business Overview
11.2.3 Yakult honsha Oxaliplatin Introduction
11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2019-2024)
11.2.5 Yakult honsha Recent Development
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Company Detail
11.3.2 Dr Reddy's laboratories Business Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
11.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2019-2024)
11.3.5 Dr Reddy's laboratories Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Introduction
11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Oxaliplatin Introduction
11.5.4 Teva Revenue in Oxaliplatin Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Oxaliplatin Introduction
11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2019-2024)
11.6.5 Fresenius Kabi Recent Development
11.7 Hospira
11.7.1 Hospira Company Detail
11.7.2 Hospira Business Overview
11.7.3 Hospira Oxaliplatin Introduction
11.7.4 Hospira Revenue in Oxaliplatin Business (2019-2024)
11.7.5 Hospira Recent Development
11.8 Mylan
11.8.1 Mylan Company Detail
11.8.2 Mylan Business Overview
11.8.3 Mylan Oxaliplatin Introduction
11.8.4 Mylan Revenue in Oxaliplatin Business (2019-2024)
11.8.5 Mylan Recent Development
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Detail
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2019-2024)
11.9.5 Jiangsu Hengrui Medicine Recent Development
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Company Detail
11.10.2 Nanjing Pharmaceutical Factory Business Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2019-2024)
11.10.5 Nanjing Pharmaceutical Factory Recent Development
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Company Detail
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Detail
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.12.5 Qilu Pharmaceutical Recent Development
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Company Detail
11.13.2 Hisun Pharmaceutical Business Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.13.5 Hisun Pharmaceutical Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Detail
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.14.5 Lunan Pharmaceutical Recent Development
11.15 Luoxin
11.15.1 Luoxin Company Detail
11.15.2 Luoxin Business Overview
11.15.3 Luoxin Oxaliplatin Introduction
11.15.4 Luoxin Revenue in Oxaliplatin Business (2019-2024)
11.15.5 Luoxin Recent Development
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Company Detail
11.16.2 Halfsky Pharmacy Business Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Introduction
11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2019-2024)
11.16.5 Halfsky Pharmacy Recent Development
11.17 YRPG
11.17.1 YRPG Company Detail
11.17.2 YRPG Business Overview
11.17.3 YRPG Oxaliplatin Introduction
11.17.4 YRPG Revenue in Oxaliplatin Business (2019-2024)
11.17.5 YRPG Recent Development
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Company Detail
11.18.2 Hainan Jinrui Pharmaceutical Business Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.18.5 Hainan Jinrui Pharmaceutical Recent Development
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Company Detail
11.19.2 Jari Pharmaceutical Business Overview
11.19.3 Jari Pharmaceutical Oxaliplatin Introduction
11.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.19.5 Jari Pharmaceutical Recent Development
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Company Detail
11.20.2 Chiatai Tianqing Business Overview
11.20.3 Chiatai Tianqing Oxaliplatin Introduction
11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2019-2024)
11.20.5 Chiatai Tianqing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Mannitol
Table 3. Key Players of Glucose Solution
Table 4. Key Players of Lactose Solution
Table 5. Key Players of Others
Table 6. Global Oxaliplatin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Oxaliplatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oxaliplatin Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Oxaliplatin Market Share by Region (2019-2024)
Table 10. Global Oxaliplatin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Oxaliplatin Market Share by Region (2025-2030)
Table 12. Oxaliplatin Market Trends
Table 13. Oxaliplatin Market Drivers
Table 14. Oxaliplatin Market Challenges
Table 15. Oxaliplatin Market Restraints
Table 16. Global Oxaliplatin Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Oxaliplatin Market Share by Players (2019-2024)
Table 18. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2023)
Table 19. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oxaliplatin Product Solution and Service
Table 23. Date of Enter into Oxaliplatin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxaliplatin Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Oxaliplatin Revenue Market Share by Type (2019-2024)
Table 27. Global Oxaliplatin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Oxaliplatin Revenue Market Share by Type (2025-2030)
Table 29. Global Oxaliplatin Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Oxaliplatin Revenue Market Share by Application (2019-2024)
Table 31. Global Oxaliplatin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Oxaliplatin Revenue Market Share by Application (2025-2030)
Table 33. North America Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Oxaliplatin Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Oxaliplatin Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Oxaliplatin Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Oxaliplatin Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Oxaliplatin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Oxaliplatin Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Oxaliplatin Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Oxaliplatin Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oxaliplatin Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oxaliplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Oxaliplatin Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Oxaliplatin Market Size by Country (2025-2030) & (US$ Million)
Table 48. Sanofi-Aventis Company Detail
Table 49. Sanofi-Aventis Business Overview
Table 50. Sanofi-Aventis Oxaliplatin Product
Table 51. Sanofi-Aventis Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 52. Sanofi-Aventis Recent Development
Table 53. Yakult honsha Company Detail
Table 54. Yakult honsha Business Overview
Table 55. Yakult honsha Oxaliplatin Product
Table 56. Yakult honsha Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 57. Yakult honsha Recent Development
Table 58. Dr Reddy's laboratories Company Detail
Table 59. Dr Reddy's laboratories Business Overview
Table 60. Dr Reddy's laboratories Oxaliplatin Product
Table 61. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 62. Dr Reddy's laboratories Recent Development
Table 63. Sun Pharmaceutical Company Detail
Table 64. Sun Pharmaceutical Business Overview
Table 65. Sun Pharmaceutical Oxaliplatin Product
Table 66. Sun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 67. Sun Pharmaceutical Recent Development
Table 68. Teva Company Detail
Table 69. Teva Business Overview
Table 70. Teva Oxaliplatin Product
Table 71. Teva Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 72. Teva Recent Development
Table 73. Fresenius Kabi Company Detail
Table 74. Fresenius Kabi Business Overview
Table 75. Fresenius Kabi Oxaliplatin Product
Table 76. Fresenius Kabi Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 77. Fresenius Kabi Recent Development
Table 78. Hospira Company Detail
Table 79. Hospira Business Overview
Table 80. Hospira Oxaliplatin Product
Table 81. Hospira Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 82. Hospira Recent Development
Table 83. Mylan Company Detail
Table 84. Mylan Business Overview
Table 85. Mylan Oxaliplatin Product
Table 86. Mylan Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 87. Mylan Recent Development
Table 88. Jiangsu Hengrui Medicine Company Detail
Table 89. Jiangsu Hengrui Medicine Business Overview
Table 90. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 91. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 92. Jiangsu Hengrui Medicine Recent Development
Table 93. Nanjing Pharmaceutical Factory Company Detail
Table 94. Nanjing Pharmaceutical Factory Business Overview
Table 95. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 96. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 97. Nanjing Pharmaceutical Factory Recent Development
Table 98. Jiangsu Aosaikang Pharmaceutical Company Detail
Table 99. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 100. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 101. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 102. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 103. Qilu Pharmaceutical Company Detail
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Oxaliplatin Product
Table 106. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 107. Qilu Pharmaceutical Recent Development
Table 108. Hisun Pharmaceutical Company Detail
Table 109. Hisun Pharmaceutical Business Overview
Table 110. Hisun Pharmaceutical Oxaliplatin Product
Table 111. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 112. Hisun Pharmaceutical Recent Development
Table 113. Lunan Pharmaceutical Company Detail
Table 114. Lunan Pharmaceutical Business Overview
Table 115. Lunan Pharmaceutical Oxaliplatin Product
Table 116. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 117. Lunan Pharmaceutical Recent Development
Table 118. Luoxin Company Detail
Table 119. Luoxin Business Overview
Table 120. Luoxin Oxaliplatin Product
Table 121. Luoxin Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 122. Luoxin Recent Development
Table 123. Halfsky Pharmacy Company Detail
Table 124. Halfsky Pharmacy Business Overview
Table 125. Halfsky Pharmacy Oxaliplatin Product
Table 126. Halfsky Pharmacy Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 127. Halfsky Pharmacy Recent Development
Table 128. YRPG Company Detail
Table 129. YRPG Business Overview
Table 130. YRPG Oxaliplatin Product
Table 131. YRPG Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 132. YRPG Recent Development
Table 133. Hainan Jinrui Pharmaceutical Company Detail
Table 134. Hainan Jinrui Pharmaceutical Business Overview
Table 135. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 136. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 137. Hainan Jinrui Pharmaceutical Recent Development
Table 138. Jari Pharmaceutical Company Detail
Table 139. Jari Pharmaceutical Business Overview
Table 140. Jari Pharmaceutical Oxaliplatin Product
Table 141. Jari Pharmaceutical Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 142. Jari Pharmaceutical Recent Development
Table 143. Chiatai Tianqing Company Detail
Table 144. Chiatai Tianqing Business Overview
Table 145. Chiatai Tianqing Oxaliplatin Product
Table 146. Chiatai Tianqing Revenue in Oxaliplatin Business (2019-2024) & (US$ Million)
Table 147. Chiatai Tianqing Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oxaliplatin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oxaliplatin Market Share by Type: 2023 VS 2030
Figure 3. Mannitol Features
Figure 4. Glucose Solution Features
Figure 5. Lactose Solution Features
Figure 6. Others Features
Figure 7. Global Oxaliplatin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oxaliplatin Market Share by Application: 2023 VS 2030
Figure 9. Colorectal Cancer Case Studies
Figure 10. Stomach Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Oxaliplatin Report Years Considered
Figure 14. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Oxaliplatin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oxaliplatin Market Share by Region: 2023 VS 2030
Figure 17. Global Oxaliplatin Market Share by Players in 2023
Figure 18. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2023
Figure 20. North America Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Oxaliplatin Market Share by Country (2019-2030)
Figure 22. United States Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Oxaliplatin Market Share by Country (2019-2030)
Figure 26. Germany Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Oxaliplatin Market Share by Region (2019-2030)
Figure 34. China Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Oxaliplatin Market Share by Country (2019-2030)
Figure 42. Mexico Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Oxaliplatin Market Share by Country (2019-2030)
Figure 46. Turkey Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Oxaliplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 49. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 50. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 51. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 53. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 54. Hospira Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 55. Mylan Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 56. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 57. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 58. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 59. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 60. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 61. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 62. Luoxin Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 63. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 64. YRPG Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 65. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 66. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 67. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs